NAAF launches new app for peer support in Norway
The Norwegian Asthma and Allergy Association (NAAF) launched an application to provide the opportunity to meet peers or relatives of those living with...
NAAF prepares for pollen season in Norway
In February, the Norwegian Asthma and Allergy Association (NAAF) issued its first pollen warning of the 2022 season through its daily national pollen alert...
EFA Annual General Meeting 2022
EFA's Annual General Meeting 2022
On 31st March 2022, EFA held its Annual General Meeting (AGM) in an online format. The AGM was followed by two membership...
CURE Asthma concludes with a final conference
March saw the conclusion of CURE, a four-year long research project funded by the European Union Programme Horizon 2020 which explored new approaches to...
Food allergy patients express concerns over substitutes to sunflower oil and labelling
Apart from terrible costs in human lives and suffering, the Russian war against Ukraine has considerable implications for food availability across Europe...
EFA 2022 Project: GUIDE Asthma
In 2022, EFA will work alongside the Global Initiative for Asthma (GINA) to further develop patient guidelines for asthma patients and their carers...
Review of the Energy Performance of Buildings Directive (EPBD): another missed opportunity to address indoor air pollution in Europe?
In December 2021, the European Commission’s Directorate General for Energy published its proposal for an updated Energy Performance of Buildings Directive...
EFA response to EU Food Information to Consumers Regulation raises concerns that gaps on food allergen information are forgotten
In December 2020, the European Commission launched the revision of the Food Information to Consumers (FIC) regulation 1169/2011, the main EU legislation...
The new Health Emergency and Response Authority unveils its first workplan
Established at the end of 2021, the Health Emergency Preparedness and Response Authority (HERA) has set up to improve EU coordinated response on the prevention,...
EU Air Quality Directives targeted survey: EFA unveils the many improvements the EU can take to protect patients from air pollution
In 2020, the European Commission launched a consultative process to review the current EU Air Quality Directives. As an organisation representing allergy,...
EFA Annual General Meeting 2022 (online)
For a third year in a row, EFA Annual General Meeting Business Session will be conducted online, after careful consultation with Members. The uncertainty...
Save the Date: CURE Asthma Project Final Conference
EFA invites you to the CURE conference: “Towards a CURE for Asthma: Accelerating Innovation in Personalised Medicine and Phage Therapies,” which takes...
Do not miss a date! EFA's International 2022 Calendar
Look forward to all the upcoming dates and activities to advocate for patients with allergy, asthma and COPD! To follow the international campaign days...
EFA participates in European Commission targeted workshop on the EU General Pharmaceuticals Legislation
In January 2022, EFA participated in a targeted workshop on the EU General Pharmaceuticals Legislation that the European Commission has opened for revision....
EFA response to European Commission consultation on the EU General Pharmaceuticals Legislation
EFA has responded to the much-awaited European Commission revision of the EU general pharmaceuticals legislation in December 2021 to ensure allergy and...
European Parliament Interest Group event on ‘Addressing unmet patient needs in allergy and asthma care’
The European Parliament Interest Group on Allergy & Asthma and EFA organised a virtual policy event on ‘Addressing unmet patient needs in allergy...
EFA joins two new Codex Alimentarius Commission electronic working groups
In recent months, EFA’s status within the Codex Alimentarius Commission (CAC) has been given a boost with our confirmation as members to several Codex...
EFA renewed as eligible organisation to the European Medicines Agency
Following an annual assessment, the European Medicines Agency (EMA), the EU regulatory agency responsible for the evaluation of medicinal products, has...
WHO Europe launches the Western Balkans Digital Health Network
In October 2021, the WHO Regional Committee for Europe launched the initiative ‘Western Balkans Digital Health Network’, with the aim to accelerate...
3TR project enters new research phase with the help of severe asthma patients
The 3TR project has entered a new phase, and is developing definitions of response and non-response to biological treatments for patients with severe asthma.
3TR...